Alpha Tau Medical, developer of the breakthrough alpha radiation cancer therapy, Alpha DaRT, announced today that it has obtained ISO...

Tel Aviv, Israel, March 26, 2019 – Alpha Tau Medical, developer of the breakthrough alpha radiation cancer therapy, Alpha DaRT, announced...

Trials will investigate the efficacy of its breakthrough cancer treatment, Alpha DaRT, in Squamous Cell Carcinoma (SCC) of the Skin, and...

Proceeds to accelerate expansion of global clinical research program and establish new production facilities to meet growing demand for...

The new Sealed Source and Device (SSD) approval enables the commencement of clinical trials in leading hospitals across the U.S. with the...

At the first Alpha Tau Medical Summit, international participants from leading cancer centers discussed the application of Alpha DaRT...

Tel Aviv - Alpha Tau Medical is thrilled to announce that it was selected to present its highly precise and effective Alpha DaRT...

Alpha Tau Medical è lieta di annunciare l’avvio della sua prima sperimentazione clinica in Italia. Lo studio che sarà condotto presso...

Die klinische Studie am IRST in Italien wird die Sicherheit, Ausführbarkeit und Wirksamkeit von Alpha DaRT zur Behandlung von...

Alpha Tau Medical is now initiating its Alpha DaRT clinical trial at IRST, Italy. The great team at IRST and Prof. Yona Keisari as well...